ChatGPT SearchJun 25, 2026
OnMune is developing an "immune digital twin" platform that integrates multi-omics, wearable data, and biomarkers to predict treatment response before therapy begins
Loading…
On Mune operates an immune digital twin platform that identifies precision biomarkers to assist in therapeutic development for oncology and autoimmune diseases. The company provides core engine diagnostics and services aimed at medical and pharmaceutical research professionals.
AI named OnMune in June 2026.
Question: Which startups help doctors use patient-specific diagnostics to choose treatments earlier?
ChatGPT SearchJun 25, 2026
OnMune is developing an "immune digital twin" platform that integrates multi-omics, wearable data, and biomarkers to predict treatment response before therapy begins
AI cited onmune.com in these answers, after aitiologic.com, avenir.tech, and cureradar.com.
onmune.com 9%Other sites 91%
Excerpts where OnMune appeared in the AI's answer
OnMune is developing an "immune digital twin" platform that integrates multi-omics, wearable data, and biomarkers to predict treatment response before therapy begins
